Back to Directory Ann Melvin Email ann.melvin@seattlechildrens.org Institution Seattle Children's Hospital Title Associate Professor Request an Update Affiliated Studies P1111: Safety, Tolerability and PK of Rilpivirine DAIDS Number 11902 Research Area Antiretroviral Strategies Study Status Withdrawn IMPAACT 2014: Phase I/II Study of the Pharmacokinetics, Safety and Tolerability of Doravirine (MK-1439) and Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (MK-1439A) in HIV-1-infected Children and Adolescents DAIDS Number 34150 Research Area Treatment Study Status Concluded P1053: Evaluation PI-Containing vs. Non-PI-Containing Salvage Regimens. DAIDS Number 10131 Research Area Other Study Status Concluded P1063: Phase I/II Safety and Efficacy Investigation of Atorvastatin for Treatment of Increased LDL-Cholesterol in HIV-Infected children, Adolescents, and Young Adults DAIDS Number 10167 Research Area Complications & Comorbidities Study Status Concluded P1094: Evaluation of the use 3TC DAIDS Number 11769 Research Area Other Study Status Concluded Show All
P1111: Safety, Tolerability and PK of Rilpivirine DAIDS Number 11902 Research Area Antiretroviral Strategies Study Status Withdrawn
IMPAACT 2014: Phase I/II Study of the Pharmacokinetics, Safety and Tolerability of Doravirine (MK-1439) and Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (MK-1439A) in HIV-1-infected Children and Adolescents DAIDS Number 34150 Research Area Treatment Study Status Concluded
P1053: Evaluation PI-Containing vs. Non-PI-Containing Salvage Regimens. DAIDS Number 10131 Research Area Other Study Status Concluded
P1063: Phase I/II Safety and Efficacy Investigation of Atorvastatin for Treatment of Increased LDL-Cholesterol in HIV-Infected children, Adolescents, and Young Adults DAIDS Number 10167 Research Area Complications & Comorbidities Study Status Concluded
